期刊文献+

盐酸法舒地尔治疗急性缺血性脑血管病的临床疗效 被引量:7

暂未订购
导出
作者 黄维惠
出处 《中国全科医学》 CAS CSCD 2007年第5期415-415,429,共2页 Chinese General Practice
  • 相关文献

参考文献8

  • 1脑卒中患者临床神经功能缺损程度评分标准(1995)[J].中华神经科杂志,1996,29(6):381-383. 被引量:15822
  • 2Barnett GH,Bose B,Little JR,et al.Effects of nomodipine on acute focal cerebral ischemia[J].Stroke,1986,17:884-890.
  • 3马景鑑,杨树源,魏伟,岳树源,钟跃,杨卫东,张大建,朱士广,朱涛,李萌,杨玉山,李牧,苏炳华,鄂正刚.盐酸法舒地尔治疗蛛网膜下腔出血所致脑血管痉挛的临床Ⅱ期试验研究[J].中华神经外科杂志,2006,22(1):36-40. 被引量:102
  • 4Mies G,Ishimaru S,Xie Y,et al.Ischemic thresholds of cerebral protein synthesis and energy state following middle cerebral artery occlusion in rat[J].J Cereb Blood Flow Metab,1991,11:753-761.
  • 5佟怀宇,余新光,许百男.盐酸法舒地尔对大鼠脑缺血-再灌注损伤的保护作用[J].军医进修学院学报,2002,23(3):167-169. 被引量:17
  • 6Yasuo K,Takaharu F,Ann M,et al.Effect of nicardipine,a Cachannel blocker,on pyruvate dehydrogenase activity and energy metabolites during cerebral ischemia and reperfusion in gerbil brain[J].Brain Research,1998,781:212-217.
  • 7Hitomi A,Satoh Si,Ikegaki I,et al.Hemorheolagical abnormaities in experimental cerebral ischemia and effects of protein kinase inhibitor on blood fluidity[J].Life Science,2000,67:1929-1939.
  • 8Shibuya M,Hirai S,Seto M,et al.Effects of fasudil in acute ischemic stroke:Results of a prospective placebo-controlled double-blind trial[J].Neurology,2005,238:31-39.

二级参考文献15

  • 1Nakamura K,Nishimura J,Hirano K,et al.Hydroxyfasudil,an active metabolice of fasudil hydrochloride,relaxes the rabbit basilar artery by disinibition of myosin light chain phosphatase.J Cereb Blood Flow Metab,2001,21:876-885.
  • 2Masumoto N,Tanabe Y,Saito M,et al.Attenuation of pressure-induced myogenic contraction and tyrosine phosphorylation by fasudil,a cerebral vasodilator,in rat cerebral artery.British journal of pharmacology,2000,130:219-230.
  • 3Takanashi Y,Ishida T,Meguro T,et al.A novel drug delivery system as prophylaxis for cerebral vasospasm.Acta Neurochir,2001,(Suppl) 77:213-215.
  • 4Masaoka H,Takasato Y,Nojiri T,et al.Clinic effect of fasudil hydrochloride for cerebral vasospasm following subarachnoid hemorrhage.Acta Neurochir,2001,(Suppl) 77:209-221.
  • 5Miriam M T,Bernhard W,Peter M S,et al.Systematic review of the prevention of delayed ischemic neurological deficits with hypertension,hypervolemia,and hemodilution therapy following subarachnoid hemorrhage.J Neurosurg,2003,98:978-984.
  • 6Nagumo H,Sasaki Y,Ono Y,et al.Rho-kinase inhibitor HA-1077 prevents rho-mediated myosin phosphatase inhibition in smooth muscle cells.Am J Physiol,2000.278:C57-C65.
  • 7Sasaki Y,Suzuki M,Hidaka H.The noval and specific rhokinase inhibitor (s)-(+) -2-Methyl-1-[(4-methyl-5 -isoquinoline) sulfony] -Homopiperazine as a probing molecule for rho-kinase-invlved pathway.Phrmacology & Therapeutics,2002,93:225-232.
  • 8Satoh Sh,Suzuki I,Ikegaki I,et al.The effects of HA 1077on the cerebral circulation after subarachnoid haemorrhage in dogs.Acta Neurochir (Wien),1991,110:185-188.
  • 9Shibuya M,Suzuki Y,Sugita K,et al.Effect of AT877 on cerebral vasospasm after aneurysmal subaracnoid hemorrhage.J Neurosurg,1992,76:571-577.
  • 10Shibuya M,Asano T,Sasaki Y.Effect of fasudil HCl,a protein kinase inhibitor,on cerebral vasospasm.Acta Neurochir,2000,(Suppl) 77:201-204.

共引文献15907

同被引文献176

引证文献7

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部